Short-term gov­ern­ment spend­ing bill in­cludes reau­tho­riza­tions of or­phan drug cred­its and oth­er phar­ma perks

As bi­par­ti­san talks for a longer-term gov­ern­ment spend­ing bill con­tin­ue, House Ap­pro­pri­a­tions Chair Rosa De­Lau­ro (D-CT) to­day filed a one-week con­tin­u­ing res­o­lu­tion to keep the gov­ern­ment fund­ed and avert a shut­down on Fri­day at mid­night.

The short-term Band-Aid al­so in­cludes sev­er­al reau­tho­riza­tions that are of in­ter­est to the phar­ma in­dus­try as they had been cut out of a re­cent­ly passed FDA-in­dus­try user fee deal, which was tagged on­to the last short-term fund­ing ex­ten­sion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER